Hepatx is developing regenerative medicine solutions.
HepaTx's investors include Y Combinator, National Institutes of Health, Sand Hill Angels, StartX (Stanford-StartX Fund), Asymmetry Ventures.
HepaTx is headquartered in Palo Alto, United States.
Hepatx is developing regenerative medicine solutions.
HepaTx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HepaTx — Funding & Investors." VCBacked, May 20, 2025, https://www.vcbacked.co/company/hepatx. Accessed October 18, 2026.
VCBacked. (2025). HepaTx — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/hepatx
{{cite web |title=HepaTx — Funding & Investors |url=https://www.vcbacked.co/company/hepatx |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated